You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment naive advanced disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial (INCB099280)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
May 19, 2023

Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Pembrolizumab, Etoposide, Cisplatin or Carboplatin
  • Milano, Italy
  • +2 more
Oct 10, 2023

Ustekinumab Among Bio-naive Crohn's Disease in China

Not yet recruiting
  • Crohn Disease
  • Hangzhou, Zhejiang, China
  • +2 more
Oct 9, 2023

NSCLC, Lung Diseases, Lung Tumors Trial in New Haven (Sitravatinib, Pembrolizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +8 more
  • New Haven, Connecticut
    Yale University
Oct 26, 2022

NSCLC (NSCLC) Trial in New York (Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • New York, New York
    Mount Sinai Hospital
Jan 23, 2023

Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

Not yet recruiting
  • Lung Adenocarcinoma
  • +3 more
  • Serplulimab and Bevacizumab injection
  • (no location specified)
Dec 21, 2022

Anemia of Chronic Kidney Disease Trial in Hackensack (Vadadustat)

Suspended
  • Anemia of Chronic Kidney Disease
  • Hackensack, New Jersey
    Research Site
Aug 23, 2022

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Patients With Advanced Treatment Naive LCNEC Trial in Tel Aviv (Durvalumab)

Recruiting
  • Patients With Advanced Treatment Naive LCNEC
  • Tel Aviv, Israel
    Assuta MC
Feb 20, 2022

NSCLC Trial in Boston, Durham (Osimertinib, Selumetinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Boston, Massachusetts
  • +3 more
Aug 1, 2022

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

Not yet recruiting
  • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
  • PERT-IJS plus trastuzumab, carboplatin and docetaxel
  • Perjeta plus trastuzumab, carboplatin and docetaxel
  • (no location specified)
Sep 21, 2023

Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)

Recruiting
  • Metastatic Hormone Naive Prostate Cancer
  • Sydney, New South Wales, Australia
  • +4 more
Nov 4, 2022

Fabry Disease Trial in Australia, Brazil, United States (AVR-RD-01)

Terminated
  • Fabry Disease
  • Hackensack, New Jersey
  • +4 more
Nov 15, 2022

IBD Trial in Paris (Biocollection)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biocollection
  • Paris, France
    Saint Antoine Hospital Service de Gastroentérologie et Nutrition
Feb 1, 2023

Tumor, Colorectal Cancer Trial in United States (NKTR-102 100 mg/m2, NKTR-102 125 mg/m2, Cetuximab)

Completed
Has Results
  • Tumor
  • Colorectal Cancer
  • NKTR-102 100 mg/m2
  • +2 more
  • Scottsdale, Arizona
  • +3 more
Jul 9, 2021

Liposarcoma, Dedifferentiated Trial (Brigimadlin)

Not yet recruiting
  • Liposarcoma, Dedifferentiated
  • (no location specified)
Sep 22, 2023

ABBV-951 Subcutaneous Infusion to Assess Change in Disease

Not yet recruiting
  • Parkinson's Disease (PD)
    • (no location specified)
    Oct 25, 2023

    Fabry Disease Trial in Taipei

    Recruiting
    • Fabry Disease
      • Taipei, Taiwan
        Investigational Site Number :1580001
      Sep 24, 2023

      Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

      Not yet recruiting
      • Metastatic Breast Cancer
      • +2 more
      • Patritumab deruxtecan
      • (no location specified)
      May 9, 2023

      Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

      Not yet recruiting
      • Advanced Clear Cell Renal Cell Carcinoma
      • Boston, Massachusetts
      • +2 more
      Jun 27, 2022

      Fabry Disease Trial in China (AL01211)

      Recruiting
      • Fabry Disease
      • Guangzhou, Guangdong, China
      • +5 more
      Nov 2, 2023

      Neuroendocrine Tumors Trial in New York (177Lu-DOTA-EB-TATE, Amino Acid Solution)

      Recruiting
      • Neuroendocrine Tumors
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jul 22, 2022

      Liver Disease Chronic, End Stage Liver DIsease, Cirrhosis Trial in Boston (LiverPAL)

      Not yet recruiting
      • Liver Disease Chronic
      • +4 more
      • LiverPAL
      • Boston, Massachusetts
        Massachusetts General Hospital
      Aug 17, 2023

      Subthalamic Deep Brain Stimulation in Advanced Parkinson's

      Active, not recruiting
      • Parkinson Disease
        • Helsinki, Finland
          Department of Neurology and department of Neurosurgery Helsinki
        Oct 18, 2023

        Spondylitis, Ankylosing Trial in Grenoble (Etanercept ® 50 mg)

        Completed
        • Spondylitis, Ankylosing
        • Etanercept ® 50 mg
        • Grenoble, France
          University Hospital Grenoble
        Jun 13, 2022